Cognita CEO on next steps for vision language models in radiology
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Contributors to top psychiatry journals fail to disclose industry payments
Amid ongoing concern over conflicts of interest that may affect medical practice, a new study found that 14%…
We’re reading about Novo Alzheimer’s trials, Bayer stroke results
Good morning, Jason Mast here filling in for Ed. Happy turkey week to all. I, for one, have…
FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
We’re reading about vaccine warnings, U.K. standoff with pharma
Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes…
Countries used to test drugs often don’t see the approved medicines, study finds
Numerous medicines are not accessible in many of the countries where they were tested before approval by the…
We’re reading about Trump and patent policies, a new malaria drug
Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are…
Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s Stelara
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
SAMHSA cuts endanger people facing addiction or mental illness
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming…
Launch prices for new drugs ‘significantly’ exceed inflation, analysis says
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
FDA approved fewer drugs in third quarter, analysis finds
The upheaval at the Food and Drug Administration appears to be taking a toll on the pharmaceutical industry,…